Consulate General of Canada Selects Elarex for CTA 2022 in Boston
Toward more durable COVID vaccines: McMaster spinout company earns key international grant
Future COVID-19 vaccines might not have to be kept so cold.
Canadian scientists create stable, affordable way to transport fragile vaccines
Canadian scientists figure out how to preserve vaccines without refrigeration
McMaster University invents new life-saving vaccine method
McMaster researchers bringing to market invention to transport fragile vaccines without refrigeration
Elarex formulation technology platforms are proven to dramatically improve temperature stabilization of biologicals, including vaccines so that they can be stored at 40°C and be as stable as they would be at -80°C